RGS RGS Healthcare Solutions

Pharmaceutical tenders in Portugal, Ireland and Greece

How hospital medicine tenders work in Portugal (SPMS and local health units), Ireland (HSE dynamic purchasing) and Greece (EKAPY central purchasing).

At a glance: All three countries lean on central purchasing. Portugal buys through SPMS framework agreements and its 39 local health units, Ireland through the Health Service Executive's dynamic purchasing system, and Greece increasingly through EKAPY, the national central authority for health procurement.

Key facts: Portugal, Ireland and Greece

Main buyersPortugal: SPMS and the 39 local health units (ULS) formed in 2024. Ireland: the Health Service Executive. Greece: EKAPY and public hospitals
Main routesPortugal: central framework agreements and ULS tenders. Ireland: a dynamic purchasing system for authorised medicines. Greece: central EKAPY tenders and negotiations
Typical termUsually one to three years
Award modelMostly price-led

How does Portugal buy hospital medicines?

SPMS runs framework agreements that the public health service buys against, some very large and awarded to a single supplier. Since January 2024 hospitals and primary care are organised in 39 local health units, which also tender in their own name.

How do Ireland and Greece buy?

Ireland's HSE buys hospital medicines mainly through a dynamic purchasing system for authorised medicinal products, with competitions run among admitted suppliers, and has a roadmap to move hospitals to best-value biologics. Community generics are not tendered; they follow interchangeable lists and reference pricing.

Greece moved high-cost hospital medicines to central purchasing through EKAPY in 2023, and the law extends this to all hospital medicines. EKAPY combines tenders with price negotiations.

How does RGS help here?

We record framework awards and admitted suppliers, follow the calendars of all three markets, and include them in the same price references as the rest of Europe.

What is public in Portugal, Ireland and Greece, and what is not

Notices and awards are published in all three countries. Portugal also publishes contracts with their value, and Greek award decisions are published as official acts.

Prices agreed in EKAPY negotiations and HSE contract prices are not published, and neither are confidential rebates agreed with the payers.

Private data, on request. RGS covers what buyers publish. For the part of the market that is never published, we set up a private pipeline for your company: your own bids and results, buyer correspondence and price lists, loaded next to the public data and visible only to your team.

Questions about Portugal, Ireland and Greece

Who buys hospital medicines in Greece?

Increasingly EKAPY, the national central authority for health procurement, which took over high-cost hospital medicines in 2023, alongside public hospitals that still run some tenders directly.

How does the HSE in Ireland buy medicines?

Mainly through a dynamic purchasing system for authorised medicinal products, in which admitted suppliers compete for each contract.

Can RGS show confidential contracts and prices in Portugal, Ireland and Greece?

No outside service can, because they are never published. RGS covers what buyers publish. For the confidential part we set up a private pipeline for your company: your own bids, results, buyer correspondence and price lists, loaded next to the public data and visible only to your team.

Guides for Portugal, Ireland and Greece

Track tenders in Portugal, Ireland and Greece on one calendar

See the open, awarded and upcoming tenders for your molecules in this market.